


主办单位:AFSUMB组委会
◆ 会议简介:
2020年第14届亚洲超声医学与生物学联合会大会暨中华医学会第二十次全国超声医学学术会议将于2020年8月27日至30日在中国北京举行,本次会议由由中华医学会、中华医学会超声医学分会主办。会议内容将涵盖超声专业基础和临床研究的国内外最新进展和发展趋势,加强相关指南和共识的继续教育和推广应用的介绍,对介入超声、斑点跟踪、弹性成像、实时三维超声显像、腔内超声、超声造影等新技术的临床应用将作重点专题研讨,就企业而言亦是难得的展示交流平台。预计有来自世界各地的3500余名专业人士与会。
亚洲超声医学与生物学联合会(AFSUMB)成立于1987年,由来自日本、中国、韩国、马来西亚等五个国家的代表联合发起成立。目前AFSUMB是WFUMB(世超联)所属六大附属区域组织中最大的一个联盟机构,WFUMB由来自50个国家的约5万名成员组成,其中包括来自亚洲16个国家的约1.8万名成员。除了AFSUMB大会之外,AFSUMB还为其成员提供多样化的教育机会,如亚洲的WFUMB COE,共同分享超声医学生物学领域的最新信息。——未经本站许可,禁止复制转载镜像本站任何内容—领域国际医学会议网。
重要时间
2020年6月30日:会议征文截止日期
2020年7月31日:会议日程公布日期
2020年8月26日:继续教育报到日期
2020年8月27日:学术大会报到日期
The 14th Congress of Asian Federation of ultrasound medicine and biology and the 20th National ultrasound medicine academic conference of Chinese Medical Association, sponsored by Chinese Medical Association and ultrasound medicine branch of Chinese Medical Association, will be held in Beijing from August 27 to August 30, 2020. This meeting is the most important academic activity of ultrasound medicine branch of Chinese Medical Association in 2020, and also one of the key international academic activities of Chinese Medical Association in 2020. It is expected that 3500 doctors at home and abroad will attend the meeting.
The meeting will cover the latest progress and development trend of basic and clinical ultrasound research at home and abroad, strengthen the introduction of continuous education and promotion application of relevant guidelines and consensus, and focus on the clinical application of new technologies such as interventional ultrasound, speckle tracking, elastic imaging, real-time three-dimensional ultrasound imaging, intracavitary ultrasound and ultrasound contrast, which is also rare for enterprises Display and exchange platform.
The ultrasonic medicine branch of the Chinese Medical Association sincerely hopes that your company will actively participate in this conference and work together to improve the level of ultrasonic medicine in China.
Looking forward to meeting in Beijing!
参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
1
文本已超出限制,最大输入200字
举报
其他